338 related articles for article (PubMed ID: 21514731)
1. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
Ernberg M; Hedenberg-Magnusson B; List T; Svensson P
Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731
[TBL] [Abstract][Full Text] [Related]
2. Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson.
Janal MN; Raphael KG
Pain; 2011 Sep; 152(9):2186-2187. PubMed ID: 21737201
[No Abstract] [Full Text] [Related]
3. BTX-A for persistent myofascial TMD pain: interpreting a small clinical trial with negative results.
Nixdorf DR
Pain; 2011 Sep; 152(9):1944-1945. PubMed ID: 21641114
[No Abstract] [Full Text] [Related]
4. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
Ojala T; Arokoski JP; Partanen J
Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
[TBL] [Abstract][Full Text] [Related]
7. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
8. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
10. An update on botulinum toxin A injections of trigger points for myofascial pain.
Zhou JY; Wang D
Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
[TBL] [Abstract][Full Text] [Related]
11. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
Li K; Tan K; Yacovelli A; Bi WG
J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
13. Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.
Christidis N; Omrani S; Fredriksson L; Gjelset M; Louca S; Hedenberg-Magnusson B; Ernberg M
J Headache Pain; 2015; 16():104. PubMed ID: 26634569
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
Chen YW; Chiu YW; Chen CY; Chuang SK
Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
[TBL] [Abstract][Full Text] [Related]
15. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
Rezazadeh F; Esnaashari N; Azad A; Emad S
BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
[TBL] [Abstract][Full Text] [Related]
16. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
17. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial.
De la Torre Canales G; Poluha RL; Bonjardim LR; Ernberg M; Conti PCR
Sci Rep; 2024 Feb; 14(1):4201. PubMed ID: 38378855
[TBL] [Abstract][Full Text] [Related]
19. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
